15/11/2019
CANCER INSURANCE
The ICEA LION Cancer Insurance Policy is designed to provide pay-outs in the event that one is diagnosed with invasive cancer or a benign brain tumour. The pay-out is classified according to the type of treatment being received. This pay-out is a percentage of the Sum Insured (or the Benefit Amount) that is paid to you in the event you are diagnosed with cancer as per the following table:
Invasive Cancer is a Cancer that has spread beyond the tissue where it developed and is growing into sorrounding, healthy tissues.
Condition/Event/Treatment Benefit Amount
Cancer diagnosis 10 % of the sum Insured.
Chemotherapy 5% of the sum Insured per each course up to a maximum of 5 courses within 5 years since initial diagnosis.
Radiotherapy 5%of the sum Insured per each course up to a maximum of 5 courses within 5 years since initial diagnosis.
Non-diagnostic cancer Surgery 20% of the sum Insured limited to 1 surgery within 5 years since initial diagnosis.
Relapse 10% of the sum Insured between year 5 and year 10 since initial diagnosis.
Remission Bonus 10% of the sum Insured after 10 years since initial diagnosis.
Palliative Care Remaining part up to 100% of sum assured.
Additional non-invasive or benign tumours
Condition/Event/Treatment Benefit Amount
Diagnosis - Benign brain tumour 10% of the sum Insured.
Surgery - Benign brain tumour 40% of the sum Insured.
A Benign Brain Tumour is a life-threatening, non-cancerous tumour of the brain as confirmed by a neurologist or neurosurgeon, giving rise to characteristics signs of increased intracranial pressure such as papilloedema, mental symptoms, seizures and motor or sensory impairment.